![\"\"](\"https:\/\/www.ukm.my\/umbi\/wp-content\/uploads\/2025\/11\/BMCC-2025-300x173.jpeg\")
<\/p>\n<\/p>\n
The UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), has been recognised at the 6th Business Excellence Awards organised by the British Malaysian Chamber of Commerce (BMCC)<\/strong>, securing Third Place in the Partnership of the Year 2025 category<\/strong>.<\/p>\n This marks the second consecutive year<\/strong> UMBI has been acknowledged at the prestigious awards, following its Second Place achievement in the same category in 2024<\/strong>, highlighting the institute\u2019s growing reputation in international research collaboration.<\/p>\n The recognition was awarded for a collaborative research project focused on analysing body composition among 6,000 individuals using Dual-Energy X-ray Absorptiometry (DXA)<\/strong> and investigating its association with non-communicable diseases (NCDs)<\/strong> such as diabetes and cardiovascular disease. In addition, magnetic resonance imaging (MRI)<\/strong> was conducted on 100 participants to further validate the findings.<\/p>\n Key findings from the study revealed that body composition varies among Malaysia\u2019s multi-ethnic population<\/strong>, which may contribute to differing risks of developing NCDs such as diabetes and heart disease. The study also demonstrated that MRI and DXA produced comparable results in assessing body composition<\/strong>, strengthening the reliability of these imaging approaches.<\/p>\n Beyond its scientific findings, the project has generated significant academic and capacity-building impact, including:<\/p>\n Establishing one of the largest imaging studies in Southeast Asia and Malaysia<\/strong> using DXA and MRI.<\/p>\n<\/li>\n Appointment of Professor Sarah Lewington from the University of Oxford<\/strong> as an Honorary Professor at UMBI.<\/p>\n<\/li>\n Placement of University of Oxford postgraduate students<\/strong> at UMBI for MSc and PhD research training.<\/p>\n<\/li>\n Development of big data analytics expertise<\/strong> among UMBI researchers.<\/p>\n<\/li>\n Production of several research publications, with additional manuscripts currently in progress.<\/p>\n<\/li>\n<\/ul>\n The achievement reflects the strength of collaborative efforts between UKM, UMBI researchers, the Faculty of Medicine UKM, and the Nuffield Department of Population Health, University of Oxford<\/strong>, alongside the support of partners including the Ministry of Higher Education (MOHE), the Medical Research Council (MRC) through the UK\u2013Malaysia Partnership for Non-Communicable Disease (My-PAIR)<\/strong> initiative, The Malaysian Cohort participants, MyCRO Sdn Bhd, and other contributors involved in the project.<\/p>\n UMBI dedicates this recognition to all collaborators and stakeholders whose commitment and partnership have contributed to advancing impactful research in population health and precision medicine.<\/p>\n<\/div>\n UMBI Receives Recognition at the 6th Business Excellence Awards by BMCC The UKM Medical Molecular Biology Institute (UMBI), Universiti Kebangsaan Malaysia (UKM), has been recognised …<\/a><\/p>\n","protected":false},"author":1001033,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_members_access_role":[],"_members_access_error":""},"categories":[66],"tags":[],"class_list":["post-104226","post","type-post","status-publish","format-standard","hentry","category-uncategorized-ms"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n
<\/div>\n—<\/div>\nSDG 3 | SDG 17<\/div>\nKeywords: Diseases, Health, Global partnership, Knowledge sharing<\/div>\n","protected":false},"excerpt":{"rendered":"